Tokyo, Japan

Yoshio Tahara

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Torii Pharmaceutical Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshio Tahara. Retrieved from https://idiyas.com/inventor/yoshio-tahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshio Tahara: Innovator in Medicinal Chemistry

Introduction

Yoshio Tahara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for serious medical conditions.

Latest Patents

Yoshio Tahara holds a patent for an ameliorative agent for cytokine release syndrome. This invention addresses critical health issues such as autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis, and Langerhans cell histiocytosis. The patent provides a medicament that includes a compound represented by a specific formula or a pharmaceutically acceptable salt thereof.

Career Highlights

Tahara is associated with Torii Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating effective treatments for complex medical conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Yoshio Tahara has collaborated with notable colleagues, including Yoshihiro Watanabe and Keisuke Suzuki. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Yoshio Tahara's contributions to medicinal chemistry and his innovative patent for treating cytokine release syndrome highlight his role as a key figure in the pharmaceutical industry. His work continues to impact the field positively, paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…